NEW YORK (GenomeWeb) – Medical diagnostics firm Alere today reported that its fourth quarter revenues fell 1 percent year over year, but increased 2 percent on an organic basis driven by strong international growth.

For the quarter ended Dec. 31, 2014, Alere reported revenue of $666.9 million compared to $673.2 million in Q4 2013, and ahead of the consensus analysts' estimate of $660.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.